-ATPase inhibitors and therapeutic uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9707211
SERIAL NO

15015403

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides trifluoromethyl pyrazolyl guanidine compounds that inhibit F1F0-ATPase, and methods of using trifluoromethyl pyrazolyl guanidine compounds as therapeutic agents to treat medical disorders, such as an immune disorder, inflammatory condition, or cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CRYSTAL PHARMATECHBIOBAY 218 XINGHU STREET SUZHOU INDUSTRIAL PARK SUZHOU 215123

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hurd, Alexander R Ann Arbor, US 14 167
Taylor, Clarke B Ann Arbor, US 26 241
Wang, Jian Banchburg, US 1906 17240
Zhou, Peng Suzhou, CN 284 6195

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 18, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 18, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00